drugset / Trial / NCT05971849

Dampening the Reproductive Axis With Continuous Kisspeptin

NCT05971849

Phase 1 Completed 8 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelOther

Summary

The goal of this study is to assess response to kisspeptin as well as the baseline patterns of luteinizing hormone (LH) secretion in individuals with polycystic ovarian syndrome (PCOS).

Timeline

Start
2023-10-06
Primary completion
2024-04-27
Completion
2024-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject kisspeptin 112-121 Peptide Intravenous